Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.

Ronald M Goldenberg Vanita R ArodaLiana K BillingsA Sia Louise ChristiansenAnders Meller DonatskyEhsan Parvaresh RiziGracjan PodgorskiKatarina RaslovaDavid C KlonoffRichard M Bergenstal

Published in: Diabetes, obesity & metabolism (2021)

Degludec, compared with glargine U100, provided more TIR and time in tight glycaemic range, and reduced nocturnal TBR in insulin-treated people with type 2 diabetes.

Keyphrases

type diabetes
glycemic control
insulin resistance
blood brain barrier
obstructive sleep apnea
metabolic syndrome
depressive symptoms
weight loss
physical activity
sleep quality